Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Hologic Wins $4.1m To Advance Zika Blood Screen

Executive Summary

The US Biomedical Advanced Research and Development Authority (BARDA) recently granted $4.1m to Hologic to advance development of a blood screen to detect Zika in the blood supply. Also, lawmakers are asking more questions about readiness in the US for detecting emerging infectious diseases and bioterrorism-related toxins.


Related Content

Hologic/Grifols, Roche Molecular Zika Tests Tapped For Blood-Screening Ramp-Up
Chembio Wins $13.2M US BARDA Contract To Develop POC Zika Tests
Feds Closer To Dx Distinguishing Zika From Dengue As HHS Tries To Plug Funding Gap
House-Senate Conferees Fight Over Zika Funds As FDA Approves More Assays


Related Companies